These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 10738231

  • 1. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
    Aquino VM, Herrera L, Sandler ES, Buchanan GR.
    Cancer; 2000 Apr 01; 88(7):1710-4. PubMed ID: 10738231
    [Abstract] [Full Text] [Related]

  • 2. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR, Coughlin J, Hawkins D, Friedman DL, Burns JL, Pendergrass T.
    Med Pediatr Oncol; 2003 Feb 01; 40(2):93-8. PubMed ID: 12461792
    [Abstract] [Full Text] [Related]

  • 3. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV.
    Cancer; 1999 Jul 01; 86(1):126-34. PubMed ID: 10391572
    [Abstract] [Full Text] [Related]

  • 4. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H, Gómez S, Ruvinsky S, Zubizarreta P, Latella A, Fraquelli L, Iturres AS, Casimir L, Debbag R.
    Cancer; 2003 Apr 01; 97(7):1775-80. PubMed ID: 12655535
    [Abstract] [Full Text] [Related]

  • 5. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D.
    Pediatrics; 2004 Oct 01; 114(4):e469-76. PubMed ID: 15466073
    [Abstract] [Full Text] [Related]

  • 6. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M, Hornedo J, Lumbreras C, Trigo JM, Colomer R, Perea S, Gómez C, Ruiz A, García-Carbonero R, Cortés-Funes H.
    Cancer; 1999 Jan 01; 85(1):213-9. PubMed ID: 9921995
    [Abstract] [Full Text] [Related]

  • 7. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A, Marchigiani D, Walsh T, Chanock S, Lewis L, Hiemenz J, Hiemenz S, Hicks JE, Gill V, Steinberg SM, Pizzo PA.
    N Engl J Med; 1999 Jul 29; 341(5):305-11. PubMed ID: 10423464
    [Abstract] [Full Text] [Related]

  • 8. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H, Rodriguez-Brieshcke T, Zubizarreta P, Latella A, Firpo V, Casimir L, Armada A, Fernández C, Cáceres E, Debbag R.
    Cancer; 2001 Apr 15; 91(8):1563-7. PubMed ID: 11301406
    [Abstract] [Full Text] [Related]

  • 9. The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
    Cherif H, Johansson E, Björkholm M, Kalin M.
    Haematologica; 2006 Feb 15; 91(2):215-22. PubMed ID: 16461306
    [Abstract] [Full Text] [Related]

  • 10. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G, Sunderland T, Chan KW, Rolston K, Mullen CA.
    Pediatr Blood Cancer; 2007 Mar 15; 48(3):273-7. PubMed ID: 16435377
    [Abstract] [Full Text] [Related]

  • 11. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
    Chamilos G, Bamias A, Efstathiou E, Zorzou PM, Kastritis E, Kostis E, Papadimitriou C, Dimopoulos MA.
    Cancer; 2005 Jun 15; 103(12):2629-35. PubMed ID: 15856427
    [Abstract] [Full Text] [Related]

  • 12. Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.
    Sung L, Feldman BM, Schwamborn G, Paczesny D, Cochrane A, Greenberg ML, Maloney AM, Hendershot EI, Naqvi A, Barrera M, Llewellyn-Thomas HA.
    J Clin Oncol; 2004 Oct 01; 22(19):3922-9. PubMed ID: 15459214
    [Abstract] [Full Text] [Related]

  • 13. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N, El-Mahallawy HA, Ahmed IA, Nassif S, El-Beshlawy A, El-Haddad A.
    Pediatr Blood Cancer; 2007 Nov 01; 49(6):786-92. PubMed ID: 17366527
    [Abstract] [Full Text] [Related]

  • 14. Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer.
    Shenep JL, Flynn PM, Baker DK, Hetherington SV, Hudson MM, Hughes WT, Patrick CC, Roberson PK, Sandlund JT, Santana VM, Sixbey JW, Slobod KS.
    Clin Infect Dis; 2001 Jan 01; 32(1):36-43. PubMed ID: 11112678
    [Abstract] [Full Text] [Related]

  • 15. [Criteria of low risk of mortality in children with neutropenia and fever during cancer chemotherapy].
    Paganini HR, Rodríguez Brieshcke T, Zubizarreta P, Latella A, Firpo V, Fernandez C, Armada A, Casimir L, Debbag R.
    Medicina (B Aires); 2001 Jan 01; 61(1):63-6. PubMed ID: 11265626
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
    Lucas KG, Brown AE, Armstrong D, Chapman D, Heller G.
    Cancer; 1996 Feb 15; 77(4):791-8. PubMed ID: 8616774
    [Abstract] [Full Text] [Related]

  • 18. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J, Paesmans M, Georgala A, Muanza F, Plehiers B, Dubreucq L, Lalami Y, Aoun M, Barette M.
    J Clin Oncol; 2006 Sep 01; 24(25):4129-34. PubMed ID: 16943529
    [Abstract] [Full Text] [Related]

  • 19. Chemoprophylaxis with ciprofloxacin in ovarian cancer patients receiving paclitaxel: a randomized trial.
    Carlson JW, Fowler JM, Mitchell SK, Carson LF, Mayer AR, Copeland LJ.
    Gynecol Oncol; 1997 May 01; 65(2):325-9. PubMed ID: 9159346
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.